Anti-Infectivity Activity of Human Salivary Secretions toward Human Immunodeficiency Virus

Abstract

The purpose of this investigation was to adapt an MT-2 cell syncytium-forming assay for measuring anti-infectivity activity of salivary secretions toward HIV and to determine the distribution of this activity in a population of healthy adult subjects. Whole saliva samples were collected from 27 volunteers, who reported that they did not belong to any group at high risk for HIV infection, and tested for anti-infectivity activity using the syncytium-forming assay. Nine of these subjects were subsequently retested on one or more occasions to assess the variability in appearance of this activity. Parotid and extraparotid salivas of six subjects were also tested. Samples were frozen immediately after collection and submitted in blinded fashion for quantitation of their anti-HIV activity using a syncytia-forming MT-2 cell assay or the p24 antigen ELISA. Nine out of the 27 subjects showed detectable anti-HIV infectivity activity. One parotid sample and one extraparotid sample out of four from subjects with positive whole salivas were positive and none of the parotid or extraparotid samples from two subjects with negative whole salivas were positive. The inhibitory activity ranged from 0.5 to 1 log 10 TCID₅₀ /ml and could not be correlated with total protein content in saliva or any specific electrophoretic component. Filtration of the saliva through an Amicon 10 filter before incubation with the virus abolished the activity. Similar studies using two other biological fluids, urine and cerebrospinal fluid, revealed no anti-HIV infectivity activity. These findings confirm the presence in saliva of inhibitory activity directed toward HIV.

References

Archibald, D.W. and G.A. Cole: In Vitro Inhibition of HIV-1 Infectivity by Human Salivas. AIDS Res. Hum. Retroviruses 6:1425-1432 (1990 ).

Fox, P.C., A. Wolff, C.-K. Yeh, J.C. Atkinson, and B.J. Baum: Saliva Inhibits HIV-I Infectivity. J. Am. Dent. Assoc. 116:635-637 (1988).

Fox, P.C., A. Wolff, C.-K. Yeh, J.C. Atkinson, and B.J. Baum: Salivary Inhibition of HIV-I Infectivity: Functional Properties and Distribution in Men, Women, and Children. J. Am. Dent. Assoc. 118:709-711 (1989).

Fultz, P.N.: Components of Saliva Inactivate Human Immunodeficiency Virus. Lancet ii:1215 (1986).

Groopman, J.E.: HTLV-III in Saliva of People with AIDS-Related Complex and Healthy Homosexual Men at Risk for AIDS. Science 226:447-449 (1984).

Hartree, E.F.: Determination of Protein: A Modification of the Lowry Method That Gives a Linear Photometric Response. Anal. Biochem. 48:422-427.

Ho, D.D., R.E. Byington, R.T. Schooley, T. Flynn, T.R. Rota, and M.S. Hirsch: Infrequency of Isolation of HTLV-III Virus from Saliva in AIDS. N. Engl. J. Med. 313:1606 (1985).

Homsy, J., G.A. Thomson-Honnebier, C. Chen-Mayer, and J.A. Levy: Detection of Human Immunodeficiency Virus (HIV) in Serum and Body Fluids by Sequential Competition ELISA. J. Virol. Methods 19:43-56 (1988).

Laemmli, U.K. and M. Favre: Maturation of the Head of Bacteriophage T4. I. DNA Packaging Events. J. Mol. Biol. 80:575-599 (1973).

10.

Levy, J.A.; and D. Greenspan: HIV in Saliva. Lancet i:1248 (1988).

11.

Reed, L.J. and H.A. Muench: A Simple Method of Estimating 50 Percent Endpoints. Am. J. Hygiene 27:493-497 (1938).

12.

Resnick, L., M.E. Busso, and D.C. Duncan: Anti-HIV Screening Technology. In: Heterosexual Transmission of AIDS, pp. 311-325 (N. Alexander, Ed.) Alan R. Liss, Inc., New York (1990 ).

13.

Yeh, C.-K., B. Handleman, P.C. Fox, and B. Baum: Further Studies of Salivary Inhibition of HIV-1 Infectivity. J. Acq. Immun. Def. Synd. 9:898-903 (1992).